Walleye Capital LLC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$209,420
-86.2%
61,594
-70.2%
0.00%
-100.0%
Q2 2023$1,518,495
+32.3%
206,598
+86.5%
0.01%
-70.6%
Q1 2023$1,147,650
+6.3%
110,777
+21.2%
0.02%
-15.0%
Q4 2022$1,079,458
+17.1%
91,402
+108.1%
0.02%
+17.6%
Q3 2022$922,000
+115.4%
43,931
+219.0%
0.02%
+41.7%
Q2 2022$428,000
-3.6%
13,773
+95.4%
0.01%
-20.0%
Q2 2021$444,000
+95.6%
7,050
+104.6%
0.02%
-85.8%
Q3 2018$227,0003,4450.11%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders